Αρχική World News New on NCI Websites for July 2019

New on NCI Websites for July 2019

July 2, 2019, by NCI Staff

Annual Report to the Nation on the Status of Cancer

NCI’s collection of cancer information products is constantly growing, so we provide periodic updates on new and updated content of interest to the cancer community.

Annual Report to the Nation Released

The most recent Annual Report to the Nation on the Status of Cancer shows a continuing overall decline in cancer mortality from 1999 to 2016. Published on May 30, the report also includes a review of cancer rates and trends for men and women ages 20–49 that shows lower incidence and death rates for men than women in this age group. The report is jointly issued by NCI, the Centers for Disease Control and Prevention, the North American Association of Central Cancer Registries, and the American Cancer Society.

Childhood Cancer Data Initiative Announced

The Childhood Cancer Data Initiative (CCDI) is a proposed investment to collect, analyze, and share data to address the burden of cancer in children, adolescents, and young adults. The initiative would support childhood cancer research and make it easier for researchers to learn from each of the approximately 16,000 children and adolescents diagnosed with cancer in the United States each year.

NCI Seeks Input to Help Shape CCDI

In preparation for the CCDI, NCI has launched CancerResearchIdeas, an online platform for the public to submit ideas on how to advance progress against childhood cancer through the sharing of data. And on July 29–31, scientists and leaders in childhood cancer from across the country will gather in Washington, DC, for a scientific planning meeting to discuss the role that the CCDI can play in improving childhood cancer research. Portions of the meeting will be videocast for an unlimited audience, with an opportunity to submit questions and comments.

Childhood Cancers Research Page Updated

NCI’s new Childhood Cancers Research page describes efforts by NCI and its academic and industry partners to develop new, more effective, and safer treatments for childhood cancer.

Rates of Aggressive Uterine Cancer Subtypes Rising

New findings from a study by NCI researchers show that the incidence of aggressive subtypes of uterine cancer in the United States rose rapidly during 2000 to 2015. The findings also reveal racial and ethnic disparities in uterine cancer incidence and survival.

Dialogue on Cancer Disparities, Prevention, and Research

A recording of NCI’s recent Facebook Live event “A Dialogue on Cancer Disparities, Prevention, and Research” is now available. During the event, subject matter experts from NCI and the University of Southern California discussed cancer disparities and the work being done to help reduce them.

New Division of Cancer Prevention Homepage

NCI’s Division of Cancer Prevention (DCP) has launched a dynamic new homepage to better highlight its programs, projects, and funding opportunities.

Video—Cancer Clinical Trials in Your Community

A new video, Cancer Clinical Trials in Your Community: NCI Community Oncology Research Program, highlights the research efforts of the NCI Community Oncology Research Program (NCORP) in implementing cancer clinical trials and other research studies across the country. In the video, researchers from several NCORP sites around the country talk about the importance of clinical trials to the communities they serve.

Canine Immunotherapy Trials Network

NCI’s Division of Cancer Treatment and Diagnosis (DCTD) has created a web page to increase awareness of the NCI-funded Canine Immunotherapy Trials Network. The page gives a brief history of the network and provides information about canine immunotherapy trials currently underway at participating veterinary schools.

Prostate Cancer Multidisciplinary Clinic

NCI’s Center for Cancer Research (CCR) has a new website for its Prostate Cancer Multidisciplinary Clinic. The clinic provides prostate cancer patients with a comprehensive consultation visit to discuss their diagnosis and treatment options.

Center for Cancer Research Milestones

CCR has published a new edition of CCR Milestones. This annual publication highlights some of the most important and innovative research findings from CCR investigators in the last year.

Video—Pediatric Oncology: A Tour for New Patients

In this video, Travis, a patient receiving treatment through CCR’s Pediatric Oncology Branch, leads a tour of the NIH Clinical Center. This tour shows new pediatric patients some of the faces, places, and resources that will become familiar when they come to the clinical center.

Understanding Hormone Therapy for Prostate Cancer

Hormone therapy for prostate cancer can block the production or use of male sex hormones, which fuel the disease. NCI’s Hormone Therapy for Prostate Cancer fact sheet has been updated and reorganized, with new information and new references added.

Learning about Immunotherapy Side Effects

Two new pages and one updated page about side effects people might have during treatment with cancer immunotherapy have been added to NCI’s website. The pages address organ inflammation, flu-like symptoms, and skin and nail changes and include signs to look for and what to do if they occur.

Genetic Testing for Inherited Cancer Susceptibility Syndromes

NCI’s fact sheet on genetic testing for inherited cancer susceptibility syndromes has been updated with new information about genetic testing, which tests are available, and who should think about genetic testing for cancer risk.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...